HESI Pharmacology Practice Exam

Correct Answer D: Acetylsalicylic acid (aspirin)

Explanation:

D. Acetylsalicylic acid (aspirin)

Ticlopidine hydrochloride (Ticlid) is an antiplatelet medication used to reduce the risk of stroke and other cardiovascular events by inhibiting platelet aggregation. The nurse should instruct the client to avoid taking aspirin (acetylsalicylic acid) while on ticlopidine because both medications have antiplatelet effects. Combining these two drugs can increase the risk of bleeding and hemorrhagic events. Since both medications inhibit platelet function, their concurrent use can excessively suppress blood clotting, leading to an increased risk of bruising, gastrointestinal bleeding, and other bleeding complications.

Why the Other Options Are Incorrect:

A. Vitamin C

There are no significant interactions between vitamin C and ticlopidine. Vitamin C is generally considered safe for use with ticlopidine and does not pose a bleeding risk. In fact, vitamin C may help support overall immune health and antioxidant function, and there is no contraindication for its use in this scenario.

B. Vitamin D

Similar to vitamin C, vitamin D does not interfere with ticlopidine and can be safely taken alongside this medication. Vitamin D is important for bone health and calcium regulation and does not affect platelet aggregation or increase bleeding risk.

C. Acetaminophen (Tylenol)

Acetaminophen (Tylenol) is a pain reliever and fever reducer that does not have significant antiplatelet effects. Unlike aspirin, it does not interfere with platelet function or increase the risk of bleeding when used with ticlopidine. Therefore, acetaminophen is generally safe to use for pain relief in clients taking ticlopidine.

Summary:

The nurse should advise the client to avoid acetylsalicylic acid (aspirin) (D) while taking ticlopidine (Ticlid) due to the increased risk of bleeding when both medications are used together. There are no significant interactions between vitamin C (A), vitamin D (B), or acetaminophen (C) and ticlopidine, so these can generally be used without concern.

Correct answer B: 0.5

Detailed explanation of the correct answer:

Step 1: Use the formula:

Volume to administer = Desired dose ÷ Concentration

Step 2: Plug in the values:

Desired dose = 5 mcg

Concentration = 10 mcg/mL

Volume = 5 mcg ÷ 10 mcg/mL = 0.5 mL

Explanation of why the other options are incorrect:

A. 0.2 mL would provide only 2 mcg (0.2 mL × 10 mcg/mL), which is too little.

C. 1 mL would provide 10 mcg (1 mL × 10 mcg/mL), which is too much.

D. 2 mL would provide 20 mcg (2 mL × 10 mcg/mL), which is also too much.

Summary:

To administer 5 mcg of the Hepatitis B Vaccine, the nurse should administer 0.5 mL.

Correct Answer B: 4 to 12 hours after administration

Explanation:

B. 4 to 12 hours after administration

Humulin NPH is an intermediate-acting insulin. After subcutaneous administration, it typically begins to work within 1 to 2 hours, peaks between 4 to 12 hours, and has a total duration of 18 to 24 hours. The peak action period is the time when blood glucose levels are most likely to drop, which makes 4 to 12 hours after administration the most likely window for a hypoglycemic reaction. Clients and caregivers should be taught to watch for symptoms of hypoglycemia such as sweating, shakiness, confusion, and hunger during this time.

Why the Other Options Are Incorrect:

A. 2 to 4 hours after administration

This window is too early for the peak action of NPH insulin. Although NPH begins to act around 1 to 2 hours, the risk of hypoglycemia is minimal during this early period compared to its peak.

C. 16 to 18 hours after administration

By this time, the insulin is approaching the end of its duration of action, and its activity is tapering off. This is past the peak period, making hypoglycemia less likely unless other contributing factors are present.

D. 18 to 24 hours after administration

This range represents the tail end of the insulin’s duration, with minimal circulating insulin effects remaining. Hypoglycemia during this time is not commonly expected from NPH insulin alone.

Summary:

The nurse should reinforce that the client taking Humulin NPH insulin is most likely to experience a hypoglycemic reaction 4 to 12 hours after administration (B) due to the drug’s peak action period. Options A, C, and D fall outside the typical peak range and therefore are less likely to be associated with hypoglycemia. Proper understanding of insulin action times is essential for safe diabetes management.

Correct Answer C: Consult with health care providers (HCPs) before receiving immunizations

Explanation:

When a patient is receiving an antineoplastic (chemotherapy) medication, they are often immunocompromised due to the medication's effects on the immune system. Many chemotherapy agents can weaken the immune system, making the patient more vulnerable to infections. As a result, it is crucial for the nurse to instruct the patient to consult with their healthcare provider (HCP) before receiving any immunizations, as live vaccines or certain other vaccines may not be appropriate during chemotherapy. The healthcare provider can guide the patient on which vaccines are safe to receive and when.

Explanation of Incorrect Options:

A. To take aspirin (acetylsalicylic acid) as needed for headache – This is not appropriate advice. Aspirin can increase the risk of bleeding, especially for patients undergoing chemotherapy, as chemotherapy can affect platelet counts and blood clotting. Non-steroidal anti-inflammatory drugs (NSAIDs) like aspirin should generally be avoided during chemotherapy unless specifically prescribed by the healthcare provider.

B. Drink beverages containing alcohol in moderate amounts each evening – Alcohol can interfere with the immune system, increase the risk of liver toxicity, and exacerbate side effects of chemotherapy, such as nausea and fatigue. Patients receiving chemotherapy should avoid alcohol unless specifically cleared by their healthcare provider.

D. That it is not necessary to consult HCPs before receiving a flu vaccine at the local health fair – This is incorrect. As mentioned in option C, patients receiving chemotherapy should consult their healthcare provider before receiving any vaccines, including the flu vaccine. Flu vaccines are typically inactivated (not live), but it is still crucial to consult with the healthcare provider to ensure the vaccine is appropriate for the patient’s current condition and immune status.

Summary:

Patients receiving antineoplastic medications should consult with their healthcare provider before receiving any immunizations due to their compromised immune system. Correct answer: C. Consult with health care providers (HCPs) before receiving immunizations.

Correct Answers

A Tinnitus,

B. Ototoxicity,

E. Nephrotoxicity,

F. Hypomagnesemia

Correct Answer Explanation:

A. Tinnitus

Tinnitus is an early sign of ototoxicity, a known adverse effect of cisplatin. Patients may report ringing in the ears, which can precede permanent hearing damage. Early detection is key to preventing irreversible effects.

B. Ototoxicity

Cisplatin is well known for its ototoxic potential, especially at higher or cumulative doses. It affects the cochlear hair cells in the inner ear, leading to sensorineural hearing loss. Nurses should regularly assess for any hearing changes.

E. Nephrotoxicity

Nephrotoxicity is one of the most serious adverse effects of cisplatin. It causes damage to the renal tubules, which can lead to decreased kidney function. Nurses must monitor renal labs (BUN, creatinine) and ensure proper hydration.

F. Hypomagnesemia

Cisplatin promotes magnesium wasting in the kidneys, leading to hypomagnesemia. This condition may cause muscle cramps, seizures, or cardiac arrhythmias. Regular monitoring of magnesium levels and supplementation may be necessary.

Why the Other Options Are Incorrect:

C. Hyperkalemia

Cisplatin does not typically cause hyperkalemia. It more often results in hypokalemia due to renal loss of potassium, not an increase in serum potassium levels.

D. Hypercalcemia

Cisplatin is not associated with hypercalcemia. In fact, it may sometimes contribute to hypocalcemia, particularly secondary to hypomagnesemia or renal impairment.

Summary:

The nurse should carefully monitor for tinnitus (A), ototoxicity (B), nephrotoxicity (E), and hypomagnesemia (F) in patients receiving cisplatin, as these are expected and potentially severe adverse effects. Electrolyte and renal function monitoring, along with patient education on early auditory symptoms, are critical components of care. Hyperkalemia (C) and hypercalcemia (D) are not typical adverse effects of cisplatin therapy.

Correct Answer B: Checking the frequency and consistency of bowel movements

Explanation:

B. Checking the frequency and consistency of bowel movements

Infliximab (Remicade) is a monoclonal antibody used in the treatment of inflammatory bowel diseases, including Crohn's disease. Its therapeutic goal is to reduce inflammation and control symptoms. One of the key indicators of treatment effectiveness is a decrease in the frequency and severity of bowel movements, as the medication helps to reduce inflammation in the gastrointestinal tract. Monitoring bowel function after the infusion will provide direct feedback on whether the treatment is working to control the symptoms of Crohn's disease, such as diarrhea and abdominal discomfort.

Why the Other Options Are Incorrect:

A. Monitoring the leukocyte count for 2 days after the infusion

While leukocyte counts are important for monitoring the immune system during treatment with biologics like infliximab, they are not the primary method for assessing the effectiveness of the treatment. Infliximab's primary goal is to reduce inflammation and symptoms, so monitoring clinical symptoms, such as bowel movements, is a more direct indicator of effectiveness.

C. Checking serum liver enzyme levels before and after the infusion

Liver enzymes are monitored to assess for liver toxicity, but they are not a primary measure of treatment effectiveness in Crohn’s disease. Infliximab may cause liver enzyme elevations as a side effect, but these levels do not directly correlate with improvement in disease symptoms. Monitoring liver enzymes is important for safety, but bowel symptoms provide a better indication of therapeutic response.

D. Carrying out a Hematest on gastric fluids after the infusion is completed

A Hematest on gastric fluids is used to detect blood in the stool or other gastrointestinal issues, but it is not a routine or effective way to monitor the effectiveness of infliximab therapy for Crohn’s disease. Bowel movement frequency and consistency are much more direct indicators of how well the treatment is managing the disease.

Summary:

To assess the effectiveness of infliximab in treating Crohn’s disease, the nurse should focus on monitoring the frequency and consistency of bowel movements (B). This provides a clear indication of how well the medication is controlling symptoms. The other actions, such as monitoring leukocyte counts, liver enzymes, or performing a Hematest, are either safety measures or not directly related to evaluating treatment efficacy.

Correct Answer D: Pulmonary function studies

Explanation:

Bleomycin is an antineoplastic drug that is known to cause pulmonary toxicity, including pulmonary fibrosis, which can result in long-term respiratory complications. For this reason, pulmonary function studies (such as spirometry or lung volume testing) are essential to monitor the client’s lung function while receiving bleomycin. These studies help assess the extent of any pulmonary damage and guide further treatment to prevent or minimize complications.

Explanation of Incorrect Options:

A. Echocardiography – While echocardiography may be useful for monitoring cardiovascular function, it is not specifically indicated for assessing the risks associated with bleomycin. Bleomycin’s primary toxic effects are related to the lungs, not the heart.

B. Electrocardiography – Electrocardiography (ECG) monitors the electrical activity of the heart and can identify heart rhythm issues, but it is not relevant for monitoring the potential pulmonary side effects of bleomycin.

C. Cervical radiography – Cervical radiography, or X-rays of the neck, may be relevant in some cases of squamous cell carcinoma of the larynx to assess the tumor itself or surrounding structures, but it does not monitor the pulmonary side effects associated with bleomycin.

Summary:

The nurse caring for a client receiving bleomycin intravenously anticipates that pulmonary function studies will be prescribed to monitor for potential pulmonary toxicity, a well-known side effect of bleomycin. These studies help assess the impact of the drug on lung function and provide critical information to prevent respiratory complications.

Correct Answer A: Protamine sulfate

Why this answer is correct:

Protamine sulfate is the antidote for heparin overdose or excessive anticoagulation. Heparin is a blood thinner that inhibits the formation of blood clots, and in cases where there is excessive bleeding or overanticoagulation, protamine sulfate can be administered to reverse the effects of heparin. The nurse must ensure that protamine sulfate is available on the unit in case of emergency situations where heparin reversal is needed.

Why the other options are incorrect:

B. Potassium chloride

Potassium chloride is used to correct potassium deficiencies. While hypokalemia (low potassium) can be a concern in various clinical settings, it is not related to heparin therapy. The administration of potassium chloride is not necessary for managing heparin therapy or overdose.

C. Phytonadione (vitamin K)

Phytonadione (vitamin K) is used as an antidote for warfarin (Coumadin) overdose, not for heparin overdose. Warfarin and heparin are both anticoagulants, but they work via different mechanisms. Vitamin K would not be effective in reversing the effects of heparin.

D. Aminocaproic acid (Amicar)

Aminocaproic acid is an antifibrinolytic agent used to prevent excessive bleeding in situations where fibrinolysis (the breakdown of clots) is occurring excessively, such as in bleeding disorders or post-surgical bleeding. It is not used to reverse the effects of heparin therapy.

Summary:

Protamine sulfate is the appropriate medication to reverse the anticoagulant effects of heparin, making A the correct answer.

Correct Answer D: The client is experiencing magnesium toxicity.

Explanation of Correct Answer:

Magnesium sulfate is commonly used to manage preeclampsia, particularly for its ability to prevent seizures. However, one of the side effects of magnesium sulfate is magnesium toxicity, which can occur if the drug level becomes too high in the body. Absent deep tendon reflexes (DTRs) are a key sign of magnesium toxicity, as magnesium acts as a neuromuscular blocker at high levels. Other signs of magnesium toxicity include respiratory depression, cardiac arrhythmias, and decreased urine output.

The absence of deep tendon reflexes is a serious warning sign and necessitates prompt action to stop or reduce the magnesium infusion and potentially administer calcium gluconate as an antidote to reverse toxicity.

Why the Other Options Are Incorrect:

A. The magnesium sulfate is effective.

This is incorrect because while magnesium sulfate is intended to prevent seizures in preeclampsia, absent deep tendon reflexes are a sign of magnesium toxicity, not therapeutic effectiveness. Therapeutic levels of magnesium sulfate should not result in absent reflexes, which indicates that the dose may be too high.

B. The infusion rate needs to be increased.

This is incorrect. The absence of deep tendon reflexes indicates magnesium toxicity, and the infusion rate should actually be decreased or discontinued, not increased. Increasing the infusion rate could worsen the toxicity.

C. The client is experiencing cerebral edema.

This is unlikely to be the cause of absent deep tendon reflexes. Cerebral edema is a potential complication of preeclampsia, but it is not directly associated with absent reflexes. Cerebral edema typically manifests with symptoms like headache, visual changes, nausea, and altered mental status rather than absent reflexes.

Summary:

Absence of deep tendon reflexes in a client receiving magnesium sulfate for preeclampsia indicates magnesium toxicity. The nurse should report this finding and intervene by potentially stopping the infusion and administering the appropriate antidote (e.g., calcium gluconate) to reverse the toxicity.